Emmaus Life Sciences, Inc. EMMA Financial Statement Data


2025 Q2

Submissions

Field Row 1 Row 2
adsh 0000950170-25-072520 0000950170-25-053744
cik 822370 822370
name EMMAUS LIFE SCIENCES, INC. EMMAUS LIFE SCIENCES, INC.
sic 2834 2834
countryba US US
stprba CA CA
cityba TORRANCE TORRANCE
zipba 90503 90503
bas1 21250 HAWTHORNE BOULEVARD, SUITE 800 21250 HAWTHORNE BOULEVARD, SUITE 800
bas2
baph 310-214-0065 310-214-0065
countryma US US
stprma CA CA
cityma TORRANCE TORRANCE
zipma 90503 90503
mas1 21250 HAWTHORNE BOULEVARD, SUITE 800 21250 HAWTHORNE BOULEVARD, SUITE 800
mas2
countryinc US US
stprinc DE DE
ein 870419387 870419387
former MYND ANALYTICS, INC. MYND ANALYTICS, INC.
changed 20151211 20151211
afs 4-NON 4-NON
wksi 0 0
fye 1231 1231
form 10-Q 10-K
period 20250331 20241231
fy 2025 2024
fp Q1 FY
filed 20250515 20250414
accepted 2025-05-15 15:52:00.0 2025-04-14 16:44:00.0
prevrpt 0 0
detail 1 1
instance emma-20250331_htm.xml emma-20241231_htm.xml
nciks 1 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000950170-25-053744 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax -160000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Assets 23602000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Assets Current 6767000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Comprehensive Income Net Of Tax -1274000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Convertible Notes Payable Current 16383000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Fair Value Adjustment Of Warrants 334000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Gain Loss On Embedded Derivative Note Payable From Related Party 36000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Gain Loss On Warrant Derivative Liabilities 1195000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20230930 Gains Losses On Extinguishment Of Debt -43000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Revenue Purchase Agreement;
0000950170-25-053744 20241031 Gains Losses On Restructuring Of Debt 0.0000 USD 0 us-gaap/2024 Type Of Arrangement= Note Amendment Agreement;
0000950170-25-053744 20231231 Gross Profit 28255000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Income Taxes Paid Net 83000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Inventories -650000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Other Current Liabilities -2025000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Other Noncurrent Assets -239000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Interest Expense 7383000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Liabilities Current 63555000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Net Cash Provided By Used In Financing Activities 2477000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Net Cash Provided By Used In Operating Activities -1503000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Operating Lease Liability Noncurrent 815000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Other Assets Noncurrent 222000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 54000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20231231 Prepaid Expense And Other Assets Current 1727000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Revenue From Contract With Customer Excluding Assessed Tax 6963000.0000 USD 4 us-gaap/2024 Product Or Service= Endari International;
0000950170-25-053744 20231231 Revenue From Contract With Customer Excluding Assessed Tax 636000.0000 USD 4 us-gaap/2024 Product Or Service= Product And Service Other;
0000950170-25-053744 20221231 Stockholders Equity -34091000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20221231 Stockholders Equity -2619000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20231231 Stockholders Equity 225333000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20231231 Weighted Average Number Of Diluted Shares Outstanding 53105388.0000 shares 4 us-gaap/2024
0000950170-25-072520 20250331 Accounts Payable And Accrued Liabilities Current 18313000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-072520 20241231 Convertible Notes Payable Current 17014000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Cost Of Revenue 257000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2326000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Income Tax Expense Benefit 4000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Increase Decrease In Other Current Liabilities -254000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Increase Decrease In Other Noncurrent Assets -198000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Inventory Reserve -12000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20250331 Net Cash Provided By Used In Operating Activities 279000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Notes Payable Current Excluding Convertible Notes Payable Current 3222000.0000 USD 0 0000950170-25-072520 Related Party Transactions By Related Party= Related Party;
0000950170-25-072520 20240331 Operating Expenses 4989000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Operating Lease Right Of Use Asset 1331000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 18000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 194000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Other Liabilities Noncurrent 44000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Noncurrent Liabilities;
0000950170-25-072520 20240331 Payments To Acquire Property Plant And Equipment 4000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-072520 20240331 Profit Loss -4348000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Property Plant And Equipment Net 41000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Shares Outstanding 63865571.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20231231 Stockholders Equity -16869000.0000 USD 0 us-gaap/2024 Equity Components= Receivables From Stockholder;
0000950170-25-072520 20231231 Stockholders Equity -256122000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-072520 20240331 Stockholders Equity -16869000.0000 USD 0 us-gaap/2024 Equity Components= Receivables From Stockholder;
0000950170-25-072520 20240331 Stockholders Equity -260470000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-072520 20241231 Stockholders Equity -16869000.0000 USD 0 us-gaap/2024 Equity Components= Receivables From Stockholder;
0000950170-25-072520 20241231 Stockholders Equity -262575000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-053744 20231231 Additional Paid In Capital Common Stock 225333000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 407000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 407000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20231231 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0000950170-25-053744 20231231 Conversion Feature Derivative Note Payable 451000.0000 USD 0 0000950170-25-053744
0000950170-25-053744 20241231 Conversion Feature Derivative Note Payable 162000.0000 USD 0 0000950170-25-053744
0000950170-25-053744 20241231 Cost Of Revenue 1201000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Gain Loss On Investment In Convertible Bond -297000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Gain Loss On Sale Of Loss On Leased Assets -4000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Gain Loss On Warrant Derivative Liabilities 57000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20230731 Gains Losses On Extinguishment Of Debt -81000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Revenue Purchase Agreement;
0000950170-25-053744 20241231 Income Tax Expense Benefit 29000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Other Noncurrent Liabilities -918000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -605000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Liabilities And Stockholders Equity 35179000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Loan Receivable From Affiliates 16869000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Net Cash Provided By Used In Operating Activities -2286000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Nonoperating Income Expense Including Income Loss From Equity Method Investments -7332000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Operating Lease Liability Current 1639000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 1500000.0000 USD 0 us-gaap/2024 Business Acquisition= E J Holdings Inc;
0000950170-25-053744 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -977000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Other Liabilities Current 3000000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-053744 20241231 Other Liabilities Current 5000000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-053744 20241231 Other Liabilities Noncurrent 13421000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-053744 20241231 Payments To Acquire Property Plant And Equipment 12000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Profit Loss -3733000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Property Plant And Equipment Net 59000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16869000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16900000.0000 USD 0 us-gaap/2024 Business Acquisition= E J Holdings Inc;
0000950170-25-053744 20241231 Repayments Of Notes Payable 4509000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Research And Development Expense 1189000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Revenue From Contract With Customer Excluding Assessed Tax 10000000.0000 USD 4 us-gaap/2024 Counterparty Name= Telcon Inc; Type Of Arrangement= Distribution Agreement;
0000950170-25-053744 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 2000.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20241231 Accounts Payable And Accrued Liabilities Current 16926000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -2995000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 256000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20231231 Assets Current 11509000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Capitalized Interest On Renewal Of Notes Payable 618000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Capital Lease Obligations Incurred 189000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1389000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 526000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Common Stock Shares Issued 61845963.0000 shares 0 us-gaap/2024
0000950170-25-053744 20231231 Depreciation Depletion And Amortization 32000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Foreign Currency Transaction Gain Loss Before Tax -1767000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Gain Loss On Conversion Feature Derivative Note Payable 291000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Gains Losses On Restructuring Of Debt 1032000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -6424000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Inventories -7000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Loan Receivable From Affiliates 16869000.0000 USD 4 0000950170-25-053744 Equity Components= Receivables From Stockholder;
0000950170-25-053744 20241231 Operating Income Loss -1894000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Operating Lease Right Of Use Asset 1530000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Other Comprehensive Income Loss Net Of Tax 2459000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -3086000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20231231 Other Liabilities Current 24000.0000 USD 0 us-gaap/2024 Counterparty Name= Prestige Capital Finance; Type Of Arrangement= Purchase And Sale Agreement;
0000950170-25-053744 20231231 Other Liabilities Noncurrent 17324000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-053744 20231231 Preferred Stock Value USD 0 us-gaap/2024
0000950170-25-053744 20231231 Proceeds From Notes Payable 7050000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Property Plant And Equipment Net 46000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Retained Earnings Accumulated Deficit -256122000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Revenue From Contract With Customer Excluding Assessed Tax 16653000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Revenue From Contract With Customer Excluding Assessed Tax 2669000.0000 USD 4 us-gaap/2024 Product Or Service= Endari International;
0000950170-25-053744 20241231 Revenue From Contract With Customer Excluding Assessed Tax 506000.0000 USD 4 us-gaap/2024 Product Or Service= Product And Service Other;
0000950170-25-053744 20241231 Accounts Payable And Accrued Liabilities Current 7229000.0000 USD 0 us-gaap/2024 Accounts Notes Loans And Financing Receivable By Receivable Type= Trade Discounts Allowances And Charge- Backs Government Rebates And Other Incentives And Returns;
0000950170-25-053744 20241231 Additional Paid In Capital Common Stock 225896000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-053744 20231231 Common Stock Value 62000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -19000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Gain Loss On Sale Of Property Plant Equipment -1000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20230731 Gains Losses On Extinguishment Of Debt -87000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Revenue Beased Financing Agreement;
0000950170-25-053744 20230930 Gains Losses On Extinguishment Of Debt 124000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Standard Merchant Cash Advance Agreement;
0000950170-25-053744 20241231 Income Taxes Paid Net 48000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Other Noncurrent Assets -868000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets 214000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Interest And Other Income 681000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Interest Expense 5492000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Interest Paid Net 2246000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Inventory Reserve -12000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Inventory Reserve -58000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Investment In Convertible Bond 15037000.0000 USD 0 0000950170-25-053744
0000950170-25-053744 20241231 Net Cash Provided By Used In Financing Activities -1353000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Net Cash Provided By Used In Investing Activities -432000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Net Income Loss -3733000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-053744 20241231 Net Income Loss -6453000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Nonoperating Income Expense Including Income Loss From Equity Method Investments -4530000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Notes Payable Current Excluding Convertible Notes Payable Current 3122000.0000 USD 0 0000950170-25-053744 Related Party Transactions By Related Party= Related Party;
0000950170-25-053744 20241231 Notes Payable Current Excluding Convertible Notes Payable Current 3372000.0000 USD 0 0000950170-25-053744 Related Party Transactions By Related Party= Related Party;
0000950170-25-053744 20231231 Other Assets Noncurrent 296000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 54000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 403000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 3033000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Other Liabilities Current 14681000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Other Liabilities Current 16557000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Other Liabilities Noncurrent 39000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Noncurrent Liabilities;
0000950170-25-053744 20241231 Other Liabilities Noncurrent 13465000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Proceeds From Convertible Debt 1000000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Proceeds From Related Party Debt 927000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Profit Loss -6453000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Repayments Of Related Party Debt 110000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Revenue From Contract With Customer Excluding Assessed Tax 21998000.0000 USD 4 us-gaap/2024 Product Or Service= Endari U S;
0000950170-25-053744 20241231 Revenue From Contract With Customer Excluding Assessed Tax 10000000.0000 USD 4 us-gaap/2024 Counterparty Name= Telcon Inc; Type Of Arrangement= Distribution Agreement;
0000950170-25-053744 20231231 Shares Outstanding 61845963.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20241231 Shares Outstanding 63865571.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20231231 Stockholders Equity 62000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20241231 Stockholders Equity 64000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20231231 Stock Issued During Period Value Conversion Of Convertible Securities 4071000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Accounts Payable And Accrued Liabilities Current 16951000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Accounts Payable And Accrued Liabilities Current 754000.0000 USD 0 us-gaap/2024 Counterparty Name= Telcon Inc; Product Or Service= Pharmaceutical Grade L Glutamine; Type Of Arrangement= A P I Supply Agreement;
0000950170-25-053744 20241231 Accounts Receivable Net Current 2623000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Convertible Notes Payable Current 17014000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Earnings Per Share Basic -0.0700 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Foreign Currency Transaction Gain Loss Unrealized -1911000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Gain Loss On Investment In Convertible Bond -544000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Gains Losses On Extinguishment Of Debt -821000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 General And Administrative Expense 650000.0000 USD 4 us-gaap/2024 Financial Support To Nonconsolidated Legal Entity= Standby Letters Of Credit;
0000950170-25-053744 20241231 Gross Profit 15452000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -3792000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Accounts Payable And Accrued Liabilities 4800000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Increase Decrease In Accounts Receivable 5149000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Inventory Net 1711000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Loan To Equity Method Investee -2647000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Net Income Loss -3733000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Net Income Loss -6453000.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-053744 20231231 Notes Issued1 3590000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Notes Payable Current Excluding Convertible Notes Payable Current 7093000.0000 USD 0 0000950170-25-053744 Related Party Transactions By Related Party= Nonrelated Party;
0000950170-25-053744 20241231 Operating Expenses 17346000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Operating Lease Liability Noncurrent 1839000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 403000.0000 USD 4 0000950170-25-053744 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20241231 Other Liabilities Current 1557000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Current Liabilities;
0000950170-25-053744 20231231 Other Liabilities Noncurrent 17363000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Payments To Acquire Property Plant And Equipment 17000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Preferred Stock Shares Authorized 15000000.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Preferred Stock Shares Authorized 15000000.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Preferred Stock Value USD 0 us-gaap/2024
0000950170-25-053744 20241231 Proceeds From Notes Payable 4111000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Proceeds From Related Party Convertible Debt 1000000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Repayments Of Convertible Debt 455000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Repayments Of Related Party Debt 500000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Stockholders Equity -160000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20231231 Weighted Average Number Of Shares Outstanding Basic 53105388.0000 shares 4 us-gaap/2024
0000950170-25-053744 20241231 Accounts Payable And Accrued Liabilities Current 588000.0000 USD 0 us-gaap/2024 Counterparty Name= Telcon Inc; Product Or Service= Pharmaceutical Grade L Glutamine; Type Of Arrangement= A P I Supply Agreement;
0000950170-25-053744 20231231 Amortization Of Debt Discount Premium 2568000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Amortization Of Debt Discount Premium 708000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Cash And Cash Equivalents At Carrying Value 2547000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2547000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -1158000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0000950170-25-053744 20220930 Common Stock Shares Issued 240000.0000 shares 0 us-gaap/2024 Title Of Individual= Seah Lim;
0000950170-25-053744 20231231 Common Stock Shares Outstanding 61845963.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Common Stock Shares Outstanding 63865571.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Common Stock Value 64000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Derivative Instruments And Hedges Liabilities 8000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -16000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Foreign Currency Transaction Gain Loss Before Tax -148000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20230930 Gains Losses On Extinguishment Of Debt -312000.0000 USD 0 us-gaap/2024 Transaction Type= Purchased Amount;
0000950170-25-053744 20231231 General And Administrative Expense 14891000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Income Loss From Equity Method Investments -1713000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Accounts Payable And Accrued Liabilities 1300000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Accounts Receivable -2900000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Liabilities And Stockholders Equity 23602000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Long Term Notes Payable Excluding Convertible Long Term Notes Payable 2226000.0000 USD 0 0000950170-25-053744 Related Party Transactions By Related Party= Related Party;
0000950170-25-053744 20241231 Net Cash Provided By Used In Investing Activities 2500000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Notes Issued1 260000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Operating Expenses 24715000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Operating Lease Liability Current 2423000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Operating Lease Right Of Use Asset 2337000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 197000.0000 USD 4 0000950170-25-053744 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -3086000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Prepaid Expense And Other Assets Current 1120000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Proceeds From Sale Maturity And Collections Of Investments 2232000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Proceeds From Sale Maturity And Collections Of Investments 2508000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16869000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20221231 Stockholders Equity 50000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20231231 Stock Issued During Period Shares Conversion Of Convertible Securities 12262462.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20231231 Stock Issued During Period Value Conversion Of Convertible Securities 4059000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20241231 Accounts Receivable Net Current 856000.0000 USD 0 us-gaap/2024 Accounts Notes Loans And Financing Receivable By Receivable Type= Trade Discounts Allowances And Chargebacks And Returns;
0000950170-25-053744 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 256000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Cash And Cash Equivalents At Carrying Value 1389000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-053744 20241231 Common Stock Shares Issued 63865571.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Earnings Per Share Basic -0.1000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Earnings Per Share Diluted -0.0700 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Fair Value Of Warrants Including Down Round Protection Adjustments -52000.0000 USD 4 0000950170-25-053744 Equity Components= Retained Earnings;
0000950170-25-053744 20241231 Foreign Currency Transaction Gain Loss Unrealized 245000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Gain Loss On Conversion Feature Derivative Note Payable 2773000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Gain Loss On Conversion Feature Derivative Note Payable 24000.0000 USD 4 0000950170-25-053744 Title Of Individual= Wei Peu Zen;
0000950170-25-053744 20241231 General And Administrative Expense 10687000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Interest Paid Net 2453000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Liabilities Current 61507000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Notes Payable Current Excluding Convertible Notes Payable Current 8215000.0000 USD 0 0000950170-25-053744 Related Party Transactions By Related Party= Nonrelated Party;
0000950170-25-053744 20241231 Other Comprehensive Income Loss Net Of Tax -2835000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Other Liabilities Current 10000000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Unearned Revenue; Refer Note 3 for information regarding to the unearned revenue.
0000950170-25-053744 20241231 Other Liabilities Current 10000000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Unearned Revenue;
0000950170-25-053744 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Retained Earnings Accumulated Deficit -262575000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Revenue From Contract With Customer Excluding Assessed Tax 13478000.0000 USD 4 us-gaap/2024 Product Or Service= Endari U S;
0000950170-25-053744 20231231 Selling And Marketing Expense 8635000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Share Based Compensation 1262000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20221231 Shares Outstanding 49583501.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20221231 Stockholders Equity -252337000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-053744 20241231 Stockholders Equity -56479000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Stockholders Equity -2995000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20241231 Stockholders Equity 225896000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20241231 Stockholders Equity -262575000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-053744 20231231 Stock Issued During Period Value Conversion Of Convertible Securities 12000.0000 USD 4 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 307000.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20241231 Weighted Average Number Of Shares Outstanding Basic 63234789.0000 shares 4 us-gaap/2024
0000950170-25-053744 20231231 Accounts Receivable Net Current 5524000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Accounts Receivable Net Current 1514000.0000 USD 0 us-gaap/2024 Counterparty Name= Prestige Capital Finance; Type Of Arrangement= Purchase And Sale Agreement;
0000950170-25-053744 20231231 Assets 35179000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2021000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Comprehensive Income Net Of Tax -9288000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Cost Of Revenue 1342000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Depreciation Depletion And Amortization 22000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Derivative Instruments And Hedges Liabilities 65000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Earnings Per Share Diluted -0.1000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Fair Value Of Warrants Including Down Round Protection Adjustments 52000.0000 USD 4 0000950170-25-053744 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20241231 Gains Losses On Restructuring Of Debt 1000000.0000 USD 4 us-gaap/2024 Debt Instrument= Convertible Promissory Note; Type Of Arrangement= Exchange Agreement;
0000950170-25-053744 20231231 Income Tax Expense Benefit -59000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Other Current Liabilities -1990000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Increase Decrease In Other Noncurrent Liabilities 510000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Interest And Other Income 274000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Inventory Net 1635000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Investment In Convertible Bond 20978000.0000 USD 0 0000950170-25-053744
0000950170-25-053744 20231231 Liabilities 82935000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Liabilities 80081000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20241231 Long Term Notes Payable Excluding Convertible Long Term Notes Payable 2246000.0000 USD 0 0000950170-25-053744 Related Party Transactions By Related Party= Related Party;
0000950170-25-053744 20231231 Operating Income Loss 3540000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -977000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20241231 Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 197000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20231231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 3033000.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-053744 20231231 Other Liabilities Current 1681000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Current Liabilities;
0000950170-25-053744 20241231 Other Liabilities Noncurrent 44000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Noncurrent Liabilities;
0000950170-25-053744 20231231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-053744 20241231 Proceeds From Sale Of Property Plant And Equipment 4000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Repayments Of Notes Payable 7390000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Research And Development Expense 657000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Revenue From Contract With Customer Excluding Assessed Tax 29597000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Selling And Marketing Expense 6002000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Share Based Compensation 1200000.0000 USD 4 us-gaap/2024 Plan Name= S T I P2011 And2021 Plan;
0000950170-25-053744 20241231 Share Based Compensation 256000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20241231 Share Based Compensation 256000.0000 USD 4 us-gaap/2024 Plan Name= S T I P2011 And2021 Plan;
0000950170-25-053744 20221231 Stockholders Equity 220815000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-053744 20231231 Stockholders Equity -47756000.0000 USD 0 us-gaap/2024
0000950170-25-053744 20231231 Stockholders Equity -16869000.0000 USD 0 us-gaap/2024 Equity Components= Receivables From Stockholder;
0000950170-25-053744 20231231 Stockholders Equity -256122000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-053744 20241231 Stockholders Equity -16869000.0000 USD 0 us-gaap/2024 Equity Components= Receivables From Stockholder;
0000950170-25-053744 20241231 Stock Issued During Period Shares Conversion Of Convertible Securities 2019608.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-053744 20241231 Stock Issued During Period Value Conversion Of Convertible Securities 309000.0000 USD 4 us-gaap/2024
0000950170-25-053744 20231231 Tax Benefit Recognized On Unrealized Gain On Debt Securities 100000.0000 USD 4 0000950170-25-053744
0000950170-25-053744 20241231 Weighted Average Number Of Diluted Shares Outstanding 63234789.0000 shares 4 us-gaap/2024
0000950170-25-072520 20250331 Proceeds From Notes Payable 1206000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 4000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Other Liabilities Current 1557000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Current Liabilities;
0000950170-25-072520 20250331 Other Liabilities Current 16403000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Other Liabilities Current 1303000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Current Liabilities;
0000950170-25-072520 20241231 Additional Paid In Capital Common Stock 225896000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Other Liabilities Noncurrent 13421000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-072520 20250331 Other Liabilities Noncurrent 13369000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-072520 20250331 Common Stock Shares Issued 63865571.0000 shares 0 us-gaap/2024
0000950170-25-072520 20240331 Gross Profit 2249000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Increase Decrease In Accounts Receivable -2533000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Increase Decrease In Other Noncurrent Liabilities -13000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Investment In Convertible Bond 15037000.0000 USD 0 0000950170-25-072520
0000950170-25-072520 20241231 Long Term Notes Payable Excluding Convertible Long Term Notes Payable 2246000.0000 USD 0 0000950170-25-072520 Related Party Transactions By Related Party= Related Party;
0000950170-25-072520 20250331 Long Term Notes Payable Excluding Convertible Long Term Notes Payable 2251000.0000 USD 0 0000950170-25-072520 Related Party Transactions By Related Party= Related Party;
0000950170-25-072520 20250331 Net Income Loss -2330000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Operating Income Loss -980000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Other Assets Noncurrent 222000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0000950170-25-072520 20241231 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16900000.0000 USD 0 us-gaap/2024 Business Acquisition= E J Holdings Inc;
0000950170-25-072520 20240331 Share Based Compensation 170000.0000 USD 1 us-gaap/2024 Award Type= Stock Option; Plan Name= S T I P2011 And2021 Plan;
0000950170-25-072520 20250331 Share Based Compensation 10000.0000 USD 1 us-gaap/2024 Award Type= Stock Option; Plan Name= S T I P2011 And2021 Plan;
0000950170-25-072520 20231231 Stockholders Equity -160000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20231231 Stockholders Equity 225333000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-072520 20241231 Stockholders Equity -56479000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Stockholders Equity -58601000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Assets 23602000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Assets Current 6767000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Common Stock Shares Outstanding 63865571.0000 shares 0 us-gaap/2024
0000950170-25-072520 20250331 Comprehensive Income Net Of Tax -2132000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Depreciation Depletion And Amortization 5000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Earnings Per Share Diluted -0.0700 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Foreign Currency Transaction Gain Loss Before Tax 31000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Foreign Currency Transaction Gain Loss Before Tax -152000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Foreign Currency Transaction Gain Loss Unrealized 113000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Gain Loss On Warrant Derivative Liabilities -8000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20250331 Gain Loss On Warrant Derivative Liabilities -9000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20250331 Interest And Other Income 73000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Liabilities 80081000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Liabilities And Stockholders Equity 22478000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Liabilities Current 64915000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Weighted Average Number Of Diluted Shares Outstanding 63865571.0000 shares 1 us-gaap/2024
0000950170-25-072520 20240331 Net Cash Provided By Used In Investing Activities -4000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Net Income Loss -2330000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-072520 20241231 Notes Payable Current Excluding Convertible Notes Payable Current 3372000.0000 USD 0 0000950170-25-072520 Related Party Transactions By Related Party= Related Party;
0000950170-25-072520 20250331 Operating Lease Liability Noncurrent 544000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Operating Lease Right Of Use Asset 1530000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Other Liabilities Current 16557000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Other Liabilities Noncurrent 46000.0000 USD 0 us-gaap/2024 Balance Sheet Location= Other Noncurrent Liabilities;
0000950170-25-072520 20250331 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Repayments Of Related Party Debt 150000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Revenue From Contract With Customer Excluding Assessed Tax 2506000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Revenue From Contract With Customer Excluding Assessed Tax 2344000.0000 USD 1 us-gaap/2024 Product Or Service= Endari;
0000950170-25-072520 20250331 Revenue From Contract With Customer Excluding Assessed Tax 10000000.0000 USD 1 us-gaap/2024 Counterparty Name= Telcon Inc; Type Of Arrangement= Distribution Agreement;
0000950170-25-072520 20240331 Share Based Compensation 170000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Shares Outstanding 63865571.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20241231 Stockholders Equity -2995000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20241231 Stockholders Equity 225896000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-072520 20250331 Stockholders Equity 225906000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-072520 20240331 Amortization Of Debt Discount Premium 494000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -835000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0000950170-25-072520 20250331 Common Stock Value 64000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Cost Of Revenue 225000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Depreciation Depletion And Amortization 6000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 10000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250228 Gains Losses On Extinguishment Of Debt 164000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Revenue Purchase Agreement;
0000950170-25-072520 20240331 Income Taxes Paid Net 16000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities 1472000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Notes Payable Current Excluding Convertible Notes Payable Current 7093000.0000 USD 0 0000950170-25-072520 Related Party Transactions By Related Party= Nonrelated Party;
0000950170-25-072520 20240331 Operating Income Loss -2740000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 1500000.0000 USD 0 us-gaap/2024 Business Acquisition= E J Holdings Inc;
0000950170-25-072520 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 4000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -1728000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 194000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20241231 Other Liabilities Current 10000000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Unearned Revenue; (a) Refer to Note 3 for information regarding to due to Telcon.
0000950170-25-072520 20241231 Other Liabilities Current 5000000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-072520 20250331 Other Liabilities Noncurrent 13323000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-072520 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-072520 20250331 Preferred Stock Value USD 0 us-gaap/2024
0000950170-25-072520 20240331 Selling And Marketing Expense 1937000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20231231 Shares Outstanding 61845963.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20231231 Stockholders Equity -47756000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Stockholders Equity -53644000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Stockholders Equity 64000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20250331 Weighted Average Number Of Shares Outstanding Basic 63865571.0000 shares 1 us-gaap/2024
0000950170-25-072520 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 170000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 170000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-072520 20241231 Cash And Cash Equivalents At Carrying Value 1389000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Cash And Cash Equivalents At Carrying Value 1333000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000950170-25-072520 20240331 Comprehensive Income Net Of Tax -6058000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Convertible Notes Payable Current 16864000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Derivative Instruments And Hedges Liabilities 17000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations -16000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Gain Loss On Conversion Feature Derivative Note Payable -907000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20240331 General And Administrative Expense 2869000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -4355000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Increase Decrease In Accounts Receivable -562000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Increase Decrease In Other Noncurrent Assets -215000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets -135000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Nonoperating Income Expense Including Income Loss From Equity Method Investments -1615000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20250331 Nonoperating Income Expense Including Income Loss From Equity Method Investments -1346000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20250331 Other Comprehensive Income Loss Net Of Tax 198000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax -1728000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20250331 Other Liabilities Current 10000000.0000 USD 0 us-gaap/2024 Type Of Arrangement= Unearned Revenue;
0000950170-25-072520 20241231 Other Liabilities Noncurrent 13465000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Preferred Stock Shares Authorized 15000000.0000 shares 0 us-gaap/2024
0000950170-25-072520 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000950170-25-072520 20241231 Preferred Stock Value USD 0 us-gaap/2024
0000950170-25-072520 20240331 Proceeds From Notes Payable 1400000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Profit Loss -2330000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16900000.0000 USD 0 us-gaap/2024 Business Acquisition= E J Holdings Inc;
0000950170-25-072520 20250331 Retained Earnings Accumulated Deficit -264905000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Revenue From Contract With Customer Excluding Assessed Tax 162000.0000 USD 1 us-gaap/2024 Product Or Service= Product And Service Other;
0000950170-25-072520 20241231 Revenue From Contract With Customer Excluding Assessed Tax 10000000.0000 USD 4 us-gaap/2024 Counterparty Name= Telcon Inc; Type Of Arrangement= Distribution Agreement;
0000950170-25-072520 20241231 Stockholders Equity 64000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -2995000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Amortization Of Debt Discount Premium 99000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Common Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Common Stock Shares Authorized 250000000.0000 shares 0 us-gaap/2024
0000950170-25-072520 20240331 Earnings Per Share Basic -0.0700 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Earnings Per Share Diluted -0.0400 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Gains Losses On Extinguishment Of Debt -164000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Gains Losses On Restructuring Of Debt 1032000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Income Tax Expense Benefit -7000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities 1353000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Increase Decrease In Other Noncurrent Liabilities -169000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Interest Expense 1256000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Investment In Convertible Bond 15231000.0000 USD 0 0000950170-25-072520
0000950170-25-072520 20240331 Net Cash Provided By Used In Financing Activities -955000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Other Liabilities Current 5100000.0000 USD 0 us-gaap/2024 Valuation Allowances And Reserves Type= Trade Discount;
0000950170-25-072520 20241231 Prepaid Expense And Other Assets Current 1120000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Prepaid Expense And Other Assets Current 822000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Property Plant And Equipment Net 46000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Repayments Of Convertible Debt 150000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Repayments Of Notes Payable 1251000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Retained Earnings Accumulated Deficit -262575000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Shares Outstanding 61845963.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20250331 Stockholders Equity -2797000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20250331 Stockholders Equity -16869000.0000 USD 0 us-gaap/2024 Equity Components= Receivables From Stockholder;
0000950170-25-072520 20240331 Increase Decrease In Inventories -166000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Foreign Currency Transaction Gain Loss Unrealized -141000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Gain Loss On Conversion Feature Derivative Note Payable 162000.0000 USD 1 0000950170-25-072520
0000950170-25-072520 20250331 Increase Decrease In Inventories -199000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets -298000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Accounts Payable And Accrued Liabilities Current 16926000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Additional Paid In Capital Common Stock 225906000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1389000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1333000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -56000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Common Stock Shares Outstanding 63865571.0000 shares 0 us-gaap/2024
0000950170-25-072520 20241231 Common Stock Value 64000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Conversion Feature Derivative Note Payable 162000.0000 USD 0 0000950170-25-072520
0000950170-25-072520 20241231 Derivative Instruments And Hedges Liabilities 8000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Earnings Per Share Basic -0.0400 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Gains Losses On Restructuring Of Debt 1000000.0000 USD 1 us-gaap/2024 Debt Instrument= Convertible Promissory Note; Type Of Arrangement= Exchange Agreement;
0000950170-25-072520 20240331 Interest And Other Income 147000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Interest Expense 1910000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Interest Paid Net 415000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Inventory Net 1635000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Liabilities And Stockholders Equity 23602000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Net Cash Provided By Used In Financing Activities -345000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Net Income Loss -4348000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-072520 20250331 Notes Payable Current Excluding Convertible Notes Payable Current 7420000.0000 USD 0 0000950170-25-072520 Related Party Transactions By Related Party= Nonrelated Party;
0000950170-25-072520 20250331 Operating Expenses 3161000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Operating Lease Liability Current 2423000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Operating Lease Liability Current 2676000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Weighted Average Number Of Diluted Shares Outstanding 61845963.0000 shares 1 us-gaap/2024
0000950170-25-072520 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 18000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20240331 Other Comprehensive Income Loss Net Of Tax -1710000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Preferred Stock Par Or Stated Value Per Share 0.0010 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16869000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Repayments Of Related Party Debt 350000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Research And Development Expense 176000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2406000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2253000.0000 USD 1 us-gaap/2024 Product Or Service= Endari;
0000950170-25-072520 20240331 Stockholders Equity 62000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20250331 Stockholders Equity -264905000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000950170-25-072520 20241231 Accounts Receivable Net Current 2623000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Accounts Receivable Net Current 2061000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -2797000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Assets 22478000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Assets Current 5653000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 2547000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1712000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Common Stock Shares Issued 63865571.0000 shares 0 us-gaap/2024
0000950170-25-072520 20250331 General And Administrative Expense 2339000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Gross Profit 2181000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Increase Decrease In Other Current Liabilities -316000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Interest Paid Net 873000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Inventory Net 1437000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20250331 Liabilities 81079000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Liabilities Current 63555000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Net Cash Provided By Used In Operating Activities 140000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Net Income Loss -4348000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20241231 Operating Lease Liability Noncurrent 815000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Other Assets Noncurrent 222000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20241231 Preferred Stock Shares Authorized 15000000.0000 shares 0 us-gaap/2024
0000950170-25-072520 20241231 Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock 16869000.0000 USD 0 us-gaap/2024
0000950170-25-072520 20240331 Repayments Of Convertible Debt 200000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Repayments Of Notes Payable 1805000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20240331 Research And Development Expense 183000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Revenue From Contract With Customer Excluding Assessed Tax 153000.0000 USD 1 us-gaap/2024 Product Or Service= Product And Service Other;
0000950170-25-072520 20250331 Selling And Marketing Expense 646000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20250331 Share Based Compensation 10000.0000 USD 1 us-gaap/2024
0000950170-25-072520 20231231 Stockholders Equity 62000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000950170-25-072520 20240331 Stockholders Equity -1870000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000950170-25-072520 20240331 Stockholders Equity 225503000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000950170-25-072520 20240331 Weighted Average Number Of Shares Outstanding Basic 61845963.0000 shares 1 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Amortization Of Debt Discount Premium us-gaap/2024 0 0 monetary D D Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Increase Decrease In Other Noncurrent Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Nonoperating Income Expense Including Income Loss From Equity Method Investments 0000950170-25-053744 1 0 monetary D C Nonoperating Income Expense Including Income Loss From Equity Method Investments Nonoperating income expense including income loss from equity method investments.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock us-gaap/2024 0 0 monetary I D Receivable from Shareholders or Affiliates for Issuance of Capital Stock Amount due from owner or affiliate of reporting entity for issuance of shares. Includes, but is not limited to, amount due for award under share-based payment arrangement. Excludes amount due from officer or director.
Gain Loss On Warrant Derivative Liabilities 0000950170-25-072520 1 0 monetary D C Gain Loss On Warrant Derivative Liabilities It represents as again loss on warrant derivative liabilities.
Accounts Payable And Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Repayments Of Convertible Debt us-gaap/2024 0 0 monetary D C Repayments of Convertible Debt The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Inventory Reserve 0000950170-25-072520 1 0 monetary D C Inventory Reserve Inventory reserve.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Convertible Notes Payable Current us-gaap/2024 0 0 monetary I C Convertible Notes Payable, Current Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Notes Issued1 us-gaap/2024 0 0 monetary D C Notes Issued The fair value of notes issued in noncash investing and financing activities.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Inventory Reserve 0000950170-25-053744 1 0 monetary D C Inventory Reserve Inventory reserve.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 0 0 monetary D C Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of unrealized gain (loss) from foreign currency transaction.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Interest Expense us-gaap/2024 0 0 monetary D D Interest Expense, Operating and Nonoperating Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Proceeds From Notes Payable us-gaap/2024 0 0 monetary D D Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation.
Selling And Marketing Expense us-gaap/2024 0 0 monetary D D Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Conversion of Convertible Securities Number of shares issued during the period as a result of the conversion of convertible securities.
Loan To Equity Method Investee 0000950170-25-053744 1 0 monetary D D Loan To Equity Method Investee Loan to equity method investee
Cost Of Revenue us-gaap/2024 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Proceeds From Convertible Debt us-gaap/2024 0 0 monetary D D Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Long Term Notes Payable Excluding Convertible Long Term Notes Payable 0000950170-25-053744 1 0 monetary I C Long Term Notes Payable Excluding Convertible Long Term Notes Payable Long term notes payable excluding convertible long term notes payable.
Investment In Convertible Bond 0000950170-25-072520 1 0 monetary I D Investment In Convertible Bond Investment in convertible bond.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 0 0 monetary D C Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Increase Decrease In Other Current Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Current Liabilities Amount of increase (decrease) in current liabilities classified as other.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Other Liabilities Current us-gaap/2024 0 0 monetary I C Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Repayments Of Related Party Debt us-gaap/2024 0 0 monetary D C Repayments of Related Party Debt The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
Fair Value Of Warrants Including Down Round Protection Adjustments 0000950170-25-053744 1 0 monetary D C Fair Value Of Warrants Including Down Round Protection Adjustments Fair value of warrants including down-round protection adjustments.
Nonoperating Income Expense Including Income Loss From Equity Method Investments 0000950170-25-072520 1 0 monetary D C Nonoperating Income Expense Including Income Loss From Equity Method Investments Nonoperating income expense including income loss from equity method investments.
Interest And Other Income us-gaap/2024 0 0 monetary D C Interest and Other Income The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Expenses us-gaap/2024 0 0 monetary D D Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Repayments Of Notes Payable us-gaap/2024 0 0 monetary D C Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation.
Gain Loss On Sale Of Loss On Leased Assets 0000950170-25-053744 1 0 monetary D C Gain Loss On Sale Of Loss On Leased Assets Gain loss on sale of Loss on leased assets.
Investment In Convertible Bond 0000950170-25-053744 1 0 monetary I D Investment In Convertible Bond Investment in convertible bond.
Loan Receivable From Affiliates 0000950170-25-053744 1 0 monetary D D Loan Receivable from Affiliates Loan receivable from affiliates.
Notes Payable Current Excluding Convertible Notes Payable Current 0000950170-25-053744 1 0 monetary I C Notes Payable Current Excluding Convertible Notes Payable Current Notes payable current excluding convertible notes payable current.
Gain Loss On Conversion Feature Derivative Note Payable 0000950170-25-072520 1 0 monetary D C Gain Loss On Conversion Feature Derivative Note Payable Gain (loss) on conversion feature derivative, note payable.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Conversion Feature Derivative Note Payable 0000950170-25-072520 1 0 monetary I C Conversion Feature Derivative Note Payable Conversion feature derivative, note payable.
Long Term Notes Payable Excluding Convertible Long Term Notes Payable 0000950170-25-072520 1 0 monetary I C Long Term Notes Payable Excluding Convertible Long Term Notes Payable Long term notes payable excluding convertible long term notes payable.
Additional Paid In Capital Common Stock us-gaap/2024 0 0 monetary I C Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Gains Losses On Extinguishment Of Debt us-gaap/2024 0 0 monetary D C Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
Fair Value Adjustment Of Warrants us-gaap/2024 0 0 monetary D D Fair Value Adjustment of Warrants Amount of expense (income) related to adjustment to fair value of warrant liability.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Gain Loss On Conversion Feature Derivative Note Payable 0000950170-25-053744 1 0 monetary D C Gain Loss On Conversion Feature Derivative Note Payable Gain (loss) on conversion feature derivative, note payable.
Gain Loss On Embedded Derivative Note Payable From Related Party 0000950170-25-053744 1 0 monetary D C Gain (Loss) On Embedded Derivative Note Payable From Related Party Gain (loss) on embedded derivative note payable from related party.
Gain Loss On Investment In Convertible Bond 0000950170-25-053744 1 0 monetary D C Gain Loss On Investment In Convertible Bond Gain loss on investment in convertible bond.
Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 0000950170-25-053744 1 0 monetary D C Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss Other comprehensive income (loss) reclassification adjustment for loss included in net income (loss).
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Capital Lease Obligations Incurred us-gaap/2024 0 0 monetary D C Lease Obligation Incurred Amount of increase in lease obligation from new lease.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Derivative Instruments And Hedges Liabilities us-gaap/2024 0 0 monetary I C Derivative Instruments and Hedges, Liabilities Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Proceeds From Related Party Debt us-gaap/2024 0 0 monetary D D Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
Tax Benefit Recognized On Unrealized Gain On Debt Securities 0000950170-25-053744 1 0 monetary D C Tax benefit recognized on unrealized gain on debt securities Tax benefit recognized on unrealized gain on debt securities.
Gains Losses On Restructuring Of Debt us-gaap/2024 0 0 monetary D C Gains (Losses) on Restructuring of Debt For a debtor, the aggregate gain (loss) recognized on the restructuring of payables arises from the difference between the book value of the debt before the restructuring and the fair value of the payments on the debt after restructuring is complete.
Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Noncurrent Liabilities Amount of increase (decrease) in noncurrent operating liabilities classified as other.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Proceeds From Sale Maturity And Collections Of Investments us-gaap/2024 0 0 monetary D D Proceeds from Sale, Maturity and Collection of Investments The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Capitalized Interest On Renewal Of Notes Payable 0000950170-25-053744 1 0 monetary D C Capitalized Interest on Renewal of Notes Payable Capitalized interest on renewal of notes payable.
Conversion Feature Derivative Note Payable 0000950170-25-053744 1 0 monetary I C Conversion Feature Derivative Note Payable Conversion feature derivative, note payable.
Gain Loss On Warrant Derivative Liabilities 0000950170-25-053744 1 0 monetary D C Gain Loss On Warrant Derivative Liabilities It represents as again loss on warrant derivative liabilities.
Proceeds From Related Party Convertible Debt 0000950170-25-053744 1 0 monetary D D Proceeds From Related Party Convertible Debt Proceeds from related party convertible debt.
Notes Payable Current Excluding Convertible Notes Payable Current 0000950170-25-072520 1 0 monetary I C Notes Payable Current Excluding Convertible Notes Payable Current Notes payable current excluding convertible notes payable current.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000950170-25-053744 2 9 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-053744 2 10 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0000950170-25-053744 2 11 BS 0 H Inventory Net us-gaap/2024 Inventories, net 0
0000950170-25-053744 2 12 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-053744 2 13 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-053744 2 14 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0000950170-25-053744 2 15 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Right of use assets 0
0000950170-25-053744 2 16 BS 0 H Investment In Convertible Bond 0000950170-25-053744 Investment in convertible bond 0
0000950170-25-053744 2 17 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0000950170-25-053744 2 18 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-053744 2 21 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0000950170-25-053744 2 22 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liabilities, current portion 0
0000950170-25-053744 2 23 BS 0 H Conversion Feature Derivative Note Payable 0000950170-25-053744 Conversion feature derivative, notes payable 0
0000950170-25-053744 2 24 BS 0 H Other Liabilities Current us-gaap/2024 Other current liabilities 0
0000950170-25-053744 2 25 BS 0 H Derivative Instruments And Hedges Liabilities us-gaap/2024 Warrant derivative liabilities 0
0000950170-25-053744 2 26 BS 0 H Notes Payable Current Excluding Convertible Notes Payable Current 0000950170-25-053744 Notes payable, current portion, net of discount 0
0000950170-25-053744 2 27 BS 0 H Convertible Notes Payable Current us-gaap/2024 Convertible notes payable, net of discount 0
0000950170-25-053744 2 28 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-053744 2 29 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities, less current portion 0
0000950170-25-053744 2 30 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other long-term liabilities 0
0000950170-25-053744 2 31 BS 0 H Long Term Notes Payable Excluding Convertible Long Term Notes Payable 0000950170-25-053744 Notes payable, less current portion, net of discount 0
0000950170-25-053744 2 32 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-053744 2 33 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingent liabilities (Note 11) 0
0000950170-25-053744 2 35 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, par value $0.001 per share, 15,000,000 shares authorized, none issued or outstanding 0
0000950170-25-053744 2 36 BS 0 H Common Stock Value us-gaap/2024 Common stock, par value $0.001 per share, 250,000,000 shares authorized, 63,865,571 and 61,845,963 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 0
0000950170-25-053744 2 37 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0000950170-25-053744 2 38 BS 0 H Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock us-gaap/2024 Net loan receivable from EJ Holdings 1
0000950170-25-053744 2 39 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0000950170-25-053744 2 40 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-053744 2 41 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders' deficit 0
0000950170-25-053744 2 42 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' deficit 0
0000950170-25-053744 3 1 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0000950170-25-053744 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, authorized 0
0000950170-25-053744 3 3 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, issued 0
0000950170-25-053744 3 4 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, outstanding 0
0000950170-25-053744 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0000950170-25-053744 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, authorized 0
0000950170-25-053744 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, issued 0
0000950170-25-053744 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, outstanding 0
0000950170-25-053744 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 REVENUES, NET 0
0000950170-25-053744 4 2 IS 0 H Cost Of Revenue us-gaap/2024 COST OF GOODS SOLD 0
0000950170-25-053744 4 3 IS 0 H Gross Profit us-gaap/2024 GROSS PROFIT 0
0000950170-25-053744 4 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-053744 4 6 IS 0 H Selling And Marketing Expense us-gaap/2024 Selling 0
0000950170-25-053744 4 7 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-053744 4 8 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-053744 4 9 IS 0 H Operating Income Loss us-gaap/2024 INCOME (LOSS) FROM OPERATIONS 0
0000950170-25-053744 4 11 IS 0 H Gains Losses On Extinguishment Of Debt us-gaap/2024 Loss on debt extinguishment 0
0000950170-25-053744 4 12 IS 0 H Gain Loss On Warrant Derivative Liabilities 0000950170-25-053744 Change in fair value of warrant derivative liabilities 0
0000950170-25-053744 4 13 IS 0 H Gain Loss On Conversion Feature Derivative Note Payable 0000950170-25-053744 Change in fair value of conversion feature derivative, notes payable 0
0000950170-25-053744 4 14 IS 0 H Gain Loss On Investment In Convertible Bond 0000950170-25-053744 Realized loss on investment in convertible bond 0
0000950170-25-053744 4 15 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 Net loss on equity method investment 0
0000950170-25-053744 4 16 IS 0 H Gains Losses On Restructuring Of Debt us-gaap/2024 Gain on restructured debt 0
0000950170-25-053744 4 17 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign exchange loss 0
0000950170-25-053744 4 18 IS 0 H Interest And Other Income us-gaap/2024 Interest and other income (net) 0
0000950170-25-053744 4 19 IS 0 H Interest Expense us-gaap/2024 Interest expense 1
0000950170-25-053744 4 20 IS 0 H Nonoperating Income Expense Including Income Loss From Equity Method Investments 0000950170-25-053744 Total other expense 0
0000950170-25-053744 4 21 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAXES 0
0000950170-25-053744 4 22 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax provision (benefit) 0
0000950170-25-053744 4 23 IS 0 H Net Income Loss us-gaap/2024 NET LOSS 0
0000950170-25-053744 4 25 IS 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gain (loss) on debt securities available for sale (net of tax) 0
0000950170-25-053744 4 26 IS 0 H Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 0000950170-25-053744 Reclassification adjustment for loss included in net loss 0
0000950170-25-053744 4 27 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustments 0
0000950170-25-053744 4 28 IS 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income (loss) 0
0000950170-25-053744 4 29 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 COMPREHENSIVE LOSS 0
0000950170-25-053744 4 30 IS 0 H Earnings Per Share Basic us-gaap/2024 NET LOSS PER COMMON SHARE - BASIC 0
0000950170-25-053744 4 31 IS 0 H Earnings Per Share Diluted us-gaap/2024 NET LOSS PER COMMON SHARE - DILUTED 0
0000950170-25-053744 4 32 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC 0
0000950170-25-053744 4 33 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED 0
0000950170-25-053744 5 10 EQ 0 H Stockholders Equity us-gaap/2024 Balance, beginning 0
0000950170-25-053744 5 11 EQ 0 H Shares Outstanding us-gaap/2024 Balance, beginning (in shares) 0
0000950170-25-053744 5 13 EQ 0 H Fair Value Of Warrants Including Down Round Protection Adjustments 0000950170-25-053744 Fair value of warrants including down-round protection adjustments 0
0000950170-25-053744 5 14 EQ 0 H Stock Issued During Period Value Conversion Of Convertible Securities us-gaap/2024 Convertible and promissory notes converted to shares 0
0000950170-25-053744 5 15 EQ 0 H Stock Issued During Period Shares Conversion Of Convertible Securities us-gaap/2024 Convertible and promissory notes converted to shares (in shares) 0
0000950170-25-053744 5 16 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation 0
0000950170-25-053744 5 17 EQ 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gain (loss) on debt securities available for sale (net of tax) 0
0000950170-25-053744 5 18 EQ 0 H Other Comprehensive Income Loss Reclassification Adjustment For Loss Included In Net Income Loss 0000950170-25-053744 Reclassification adjustment for loss included in net loss 0
0000950170-25-053744 5 19 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation effect 0
0000950170-25-053744 5 20 EQ 0 H Loan Receivable From Affiliates 0000950170-25-053744 Net loan receivable from EJ Holdings 1
0000950170-25-053744 5 21 EQ 0 H Net Income Loss us-gaap/2024 Net Income (Loss) 0
0000950170-25-053744 5 22 EQ 0 H Stockholders Equity us-gaap/2024 Balance, ending 0
0000950170-25-053744 5 23 EQ 0 H Shares Outstanding us-gaap/2024 Balance, ending (in shares) 0
0000950170-25-053744 6 2 CF 0 H Profit Loss us-gaap/2024 Net loss 0
0000950170-25-053744 6 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0000950170-25-053744 6 5 CF 0 H Inventory Reserve 0000950170-25-053744 Inventory reserve 1
0000950170-25-053744 6 6 CF 0 H Amortization Of Debt Discount Premium us-gaap/2024 Amortization of discount of notes payable and convertible notes payable 0
0000950170-25-053744 6 7 CF 0 H Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 Foreign exchange adjustments 1
0000950170-25-053744 6 8 CF 0 H Tax Benefit Recognized On Unrealized Gain On Debt Securities 0000950170-25-053744 Tax benefit recognized on unrealized gain on debt securities 1
0000950170-25-053744 6 9 CF 0 H Gain Loss On Investment In Convertible Bond 0000950170-25-053744 Realized loss on investment in convertible bond 1
0000950170-25-053744 6 10 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Loss on equity method investment 1
0000950170-25-053744 6 11 CF 0 H Gains Losses On Extinguishment Of Debt us-gaap/2024 Loss on debt extinguishment 1
0000950170-25-053744 6 12 CF 0 H Gains Losses On Restructuring Of Debt us-gaap/2024 Gain on restructured debt 1
0000950170-25-053744 6 13 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 Loss on disposal of property and equipment 1
0000950170-25-053744 6 14 CF 0 H Gain Loss On Sale Of Loss On Leased Assets 0000950170-25-053744 Loss on leased assets 1
0000950170-25-053744 6 15 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation 0
0000950170-25-053744 6 16 CF 0 H Fair Value Adjustment Of Warrants us-gaap/2024 Fair value of warrants issued for services 0
0000950170-25-053744 6 17 CF 0 H Gain Loss On Warrant Derivative Liabilities 0000950170-25-053744 Change in fair value of warrant derivative liabilities 1
0000950170-25-053744 6 18 CF 0 H Gain Loss On Conversion Feature Derivative Note Payable 0000950170-25-053744 Change in fair value of conversion feature derivative, notes payable 1
0000950170-25-053744 6 19 CF 0 H Gain Loss On Embedded Derivative Note Payable From Related Party 0000950170-25-053744 Changes in fair value of embedded derivative, note payable from related party 1
0000950170-25-053744 6 21 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0000950170-25-053744 6 22 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0000950170-25-053744 6 23 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000950170-25-053744 6 24 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other non-current assets 1
0000950170-25-053744 6 25 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0000950170-25-053744 6 26 CF 0 H Increase Decrease In Other Current Liabilities us-gaap/2024 Other current liabilities 0
0000950170-25-053744 6 27 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 Other long-term liabilities 0
0000950170-25-053744 6 28 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash flows used in operating activities 0
0000950170-25-053744 6 30 CF 0 H Proceeds From Sale Maturity And Collections Of Investments us-gaap/2024 Proceeds from sale of convertible bond 0
0000950170-25-053744 6 31 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Sales of property and equipment 0
0000950170-25-053744 6 32 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0000950170-25-053744 6 33 CF 0 H Loan To Equity Method Investee 0000950170-25-053744 Loan to equity method investee 0
0000950170-25-053744 6 34 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash flows provided by (used in) investing activities 0
0000950170-25-053744 6 36 CF 0 H Proceeds From Notes Payable us-gaap/2024 Proceeds from notes payable issued 0
0000950170-25-053744 6 37 CF 0 H Proceeds From Related Party Debt us-gaap/2024 Proceeds from notes payable issued, related parties 0
0000950170-25-053744 6 38 CF 0 H Proceeds From Convertible Debt us-gaap/2024 Proceeds from convertible notes payable issued 0
0000950170-25-053744 6 39 CF 0 H Proceeds From Related Party Convertible Debt 0000950170-25-053744 Proceeds from convertible notes payable issued, related party 0
0000950170-25-053744 6 40 CF 0 H Repayments Of Notes Payable us-gaap/2024 Payments of notes payable 1
0000950170-25-053744 6 41 CF 0 H Repayments Of Related Party Debt us-gaap/2024 Payments of notes payable, related party 1
0000950170-25-053744 6 42 CF 0 H Repayments Of Convertible Debt us-gaap/2024 Payments of convertible notes 1
0000950170-25-053744 6 43 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash flows provided by (used in) financing activities 0
0000950170-25-053744 6 44 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Effect of exchange rate changes on cash 0
0000950170-25-053744 6 45 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net decrease in cash and cash equivalents 0
0000950170-25-053744 6 46 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and cash equivalents, beginning of year 0
0000950170-25-053744 6 47 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and cash equivalents, end of year 0
0000950170-25-053744 6 49 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0000950170-25-053744 6 50 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes paid (refunded) 0
0000950170-25-053744 6 52 CF 0 H Capitalized Interest On Renewal Of Notes Payable 0000950170-25-053744 Capitalized interest on renewal of notes payable 0
0000950170-25-053744 6 53 CF 0 H Notes Issued1 us-gaap/2024 Conversion of convertible note payable to common stock 0
0000950170-25-053744 6 54 CF 0 H Capital Lease Obligations Incurred us-gaap/2024 Newly acquired right-of-use lease asset 0
0000950170-25-072520 2 9 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000950170-25-072520 2 10 BS 0 H Accounts Receivable Net Current us-gaap/2024 Accounts receivable, net 0
0000950170-25-072520 2 11 BS 0 H Inventory Net us-gaap/2024 Inventories, net 0
0000950170-25-072520 2 12 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000950170-25-072520 2 13 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0000950170-25-072520 2 14 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0000950170-25-072520 2 15 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Right of use assets 0
0000950170-25-072520 2 16 BS 0 H Investment In Convertible Bond 0000950170-25-072520 Investment in convertible bond 0
0000950170-25-072520 2 17 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0000950170-25-072520 2 18 BS 0 H Assets us-gaap/2024 Total assets 0
0000950170-25-072520 2 21 BS 0 H Accounts Payable And Accrued Liabilities Current us-gaap/2024 Accounts payable and accrued expenses 0
0000950170-25-072520 2 22 BS 0 H Operating Lease Liability Current us-gaap/2024 Operating lease liabilities, current portion 0
0000950170-25-072520 2 23 BS 0 H Conversion Feature Derivative Note Payable 0000950170-25-072520 Conversion feature derivative, notes payable 0
0000950170-25-072520 2 24 BS 0 H Other Liabilities Current us-gaap/2024 Other current liabilities 0
0000950170-25-072520 2 25 BS 0 H Derivative Instruments And Hedges Liabilities us-gaap/2024 Warrant derivative liabilities 0
0000950170-25-072520 2 26 BS 0 H Notes Payable Current Excluding Convertible Notes Payable Current 0000950170-25-072520 Notes payable, current portion, net of discount 0
0000950170-25-072520 2 27 BS 0 H Convertible Notes Payable Current us-gaap/2024 Convertible notes payable, net of discount 0
0000950170-25-072520 2 28 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0000950170-25-072520 2 29 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities, less current portion 0
0000950170-25-072520 2 30 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other long-term liabilities 0
0000950170-25-072520 2 31 BS 0 H Long Term Notes Payable Excluding Convertible Long Term Notes Payable 0000950170-25-072520 Notes payable, less current portion, net of discount 0
0000950170-25-072520 2 32 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0000950170-25-072520 2 33 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingent liabilities (Note 11) 0
0000950170-25-072520 2 35 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, par value $0.001 per share, 15,000,000 shares authorized, none issued or outstanding 0
0000950170-25-072520 2 36 BS 0 H Common Stock Value us-gaap/2024 Common stock, par value $0.001 per share, 250,000,000 shares authorized, 63,865,571 shares issued and outstanding at March 31, 2025 and December 31, 2024 0
0000950170-25-072520 2 37 BS 0 H Additional Paid In Capital Common Stock us-gaap/2024 Additional paid-in capital 0
0000950170-25-072520 2 38 BS 0 H Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock us-gaap/2024 Net loan receivable from EJ Holdings 1
0000950170-25-072520 2 39 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0000950170-25-072520 2 40 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000950170-25-072520 2 41 BS 0 H Stockholders Equity us-gaap/2024 Total stockholders deficit 0
0000950170-25-072520 2 42 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities and stockholders' deficit 0
0000950170-25-072520 3 1 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0000950170-25-072520 3 2 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, authorized 0
0000950170-25-072520 3 3 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, issued 0
0000950170-25-072520 3 4 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, outstanding 0
0000950170-25-072520 3 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0000950170-25-072520 3 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, authorized 0
0000950170-25-072520 3 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, issued 0
0000950170-25-072520 3 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, outstanding 0
0000950170-25-072520 4 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 REVENUES, NET 0
0000950170-25-072520 4 2 IS 0 H Cost Of Revenue us-gaap/2024 COST OF GOODS SOLD 0
0000950170-25-072520 4 3 IS 0 H Gross Profit us-gaap/2024 GROSS PROFIT 0
0000950170-25-072520 4 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development 0
0000950170-25-072520 4 6 IS 0 H Selling And Marketing Expense us-gaap/2024 Selling 0
0000950170-25-072520 4 7 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0000950170-25-072520 4 8 IS 0 H Operating Expenses us-gaap/2024 Total operating expenses 0
0000950170-25-072520 4 9 IS 0 H Operating Income Loss us-gaap/2024 LOSS FROM OPERATIONS 0
0000950170-25-072520 4 11 IS 0 H Gains Losses On Extinguishment Of Debt us-gaap/2024 Loss on debt extinguishment 0
0000950170-25-072520 4 12 IS 0 H Gain Loss On Warrant Derivative Liabilities 0000950170-25-072520 Change in fair value of warrant derivative liabilities 0
0000950170-25-072520 4 13 IS 0 H Gain Loss On Conversion Feature Derivative Note Payable 0000950170-25-072520 Change in fair value of conversion feature derivative, notes payable 0
0000950170-25-072520 4 14 IS 0 H Gains Losses On Restructuring Of Debt us-gaap/2024 Gain on restructured debt 0
0000950170-25-072520 4 15 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign exchange gain (loss) 0
0000950170-25-072520 4 16 IS 0 H Interest And Other Income us-gaap/2024 Interest and other income (net) 0
0000950170-25-072520 4 17 IS 0 H Interest Expense us-gaap/2024 Interest expense 1
0000950170-25-072520 4 18 IS 0 H Nonoperating Income Expense Including Income Loss From Equity Method Investments 0000950170-25-072520 Total other expense 0
0000950170-25-072520 4 19 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 LOSS BEFORE INCOME TAXES 0
0000950170-25-072520 4 20 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax provision (benefit) 0
0000950170-25-072520 4 21 IS 0 H Net Income Loss us-gaap/2024 NET LOSS 0
0000950170-25-072520 4 23 IS 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gain (loss) on debt securities available for sale (net of tax) 0
0000950170-25-072520 4 24 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustment 0
0000950170-25-072520 4 25 IS 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income (loss) 0
0000950170-25-072520 4 26 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 COMPREHENSIVE LOSS 0
0000950170-25-072520 4 27 IS 0 H Earnings Per Share Basic us-gaap/2024 NET INCOME (LOSS) PER COMMON SHARE - BASIC 0
0000950170-25-072520 4 28 IS 0 H Earnings Per Share Diluted us-gaap/2024 NET LOSS PER COMMON SHARE - DILUTED 0
0000950170-25-072520 4 29 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - BASIC 0
0000950170-25-072520 4 30 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING - DILUTED 0
0000950170-25-072520 5 10 EQ 0 H Stockholders Equity us-gaap/2024 Balance, beginning 0
0000950170-25-072520 5 11 EQ 0 H Shares Outstanding us-gaap/2024 Balance, beginning (in shares) 0
0000950170-25-072520 5 13 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation 0
0000950170-25-072520 5 14 EQ 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Unrealized gain (loss) on debt securities available for sale (net of tax) 0
0000950170-25-072520 5 15 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation effect 0
0000950170-25-072520 5 16 EQ 0 H Net Income Loss us-gaap/2024 Net Income (Loss) 0
0000950170-25-072520 5 17 EQ 0 H Stockholders Equity us-gaap/2024 Balance, ending 0
0000950170-25-072520 5 18 EQ 0 H Shares Outstanding us-gaap/2024 Balance, ending (in shares) 0
0000950170-25-072520 6 2 CF 0 H Profit Loss us-gaap/2024 Net loss 0
0000950170-25-072520 6 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0000950170-25-072520 6 5 CF 0 H Inventory Reserve 0000950170-25-072520 Inventory reserve 1
0000950170-25-072520 6 6 CF 0 H Amortization Of Debt Discount Premium us-gaap/2024 Amortization of discount of notes payable and convertible notes payable 0
0000950170-25-072520 6 7 CF 0 H Foreign Currency Transaction Gain Loss Unrealized us-gaap/2024 Foreign exchange adjustments 1
0000950170-25-072520 6 8 CF 0 H Gains Losses On Extinguishment Of Debt us-gaap/2024 Loss on debt extinguishment 1
0000950170-25-072520 6 9 CF 0 H Gains Losses On Restructuring Of Debt us-gaap/2024 Gain on restructured debt 1
0000950170-25-072520 6 10 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation 0
0000950170-25-072520 6 11 CF 0 H Gain Loss On Warrant Derivative Liabilities 0000950170-25-072520 Change in fair value of warrant derivative liabilities 1
0000950170-25-072520 6 12 CF 0 H Gain Loss On Conversion Feature Derivative Note Payable 0000950170-25-072520 Change in fair value of conversion feature derivative, notes payable 1
0000950170-25-072520 6 14 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Accounts receivable 1
0000950170-25-072520 6 15 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories 1
0000950170-25-072520 6 16 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000950170-25-072520 6 17 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other non-current assets 1
0000950170-25-072520 6 18 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Accounts payable and accrued expenses 0
0000950170-25-072520 6 19 CF 0 H Increase Decrease In Other Current Liabilities us-gaap/2024 Other current liabilities 0
0000950170-25-072520 6 20 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 Other long-term liabilities 0
0000950170-25-072520 6 21 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash flows provided by operating activities 0
0000950170-25-072520 6 23 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchases of property and equipment 1
0000950170-25-072520 6 24 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash flows used in investing activities 0
0000950170-25-072520 6 26 CF 0 H Proceeds From Notes Payable us-gaap/2024 Proceeds from notes payable issued 0
0000950170-25-072520 6 27 CF 0 H Repayments Of Notes Payable us-gaap/2024 Payments of notes payable 1
0000950170-25-072520 6 28 CF 0 H Repayments Of Related Party Debt us-gaap/2024 Payments of notes payable, related party 1
0000950170-25-072520 6 29 CF 0 H Repayments Of Convertible Debt us-gaap/2024 Payments of convertible notes 1
0000950170-25-072520 6 30 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash flows used in financing activities 0
0000950170-25-072520 6 31 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Effect of exchange rate changes on cash 0
0000950170-25-072520 6 32 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net decrease in cash and cash equivalents 0
0000950170-25-072520 6 33 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and cash equivalents, beginning of year 0
0000950170-25-072520 6 34 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations us-gaap/2024 Cash and cash equivalents, end of year 0
0000950170-25-072520 6 36 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0000950170-25-072520 6 37 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes paid 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.